Clinical Trials Logo

Clinical Trial Summary

The Novapak study is a prospective, observational, multi-site, non-controlled, non-randomized, case-series, with a 2 week and 1-month follow-up in adults undergoing nasal/sinus surgery with Novapak Nasal Sinus Packing and Stent device used as indicated post-operatively and is being conducted to obtain clinical data on the safety and effectiveness of the Novapak device under use as intended in the device indications.


Clinical Trial Description

The primary objective is to assess the safety of the Novapak Nasal Sinus Packing and Stent device used as indicated post-operatively in patients undergoing nasal/sinus surgery by: - Collecting all AEs directly attributed to the device and/or those that cannot be determined; and calculating a point estimate and confidence interval - Collecting all AEs and calculating an overall rate and safety profile for the device The secondary objectives are to confirm device effectiveness through assessing adhesions, bleeding, healing and health during the procedure, 2 weeks and 1-month post treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05747014
Study type Observational
Source Medtronic Surgical Technologies
Contact
Status Completed
Phase
Start date March 9, 2023
Completion date December 13, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01960816 - InFlux System for Nasal Breathing Improvement N/A
Enrolling by invitation NCT03233373 - Thermal Imaging as a Potential Diagnostic Tool of Nasal Airflow
Recruiting NCT05527652 - Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia N/A
Recruiting NCT06163404 - Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant N/A
Active, not recruiting NCT04549545 - Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study N/A
Active, not recruiting NCT05446714 - Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE) N/A